Skip to content

Real World Study on Registration and Follow up of Patients with Lower Limb Arteriosclerosis Occlusion after Interventional Surgery in China

Real World Study on Registration and Follow up of Patients with Lower Limb Arteriosclerosis Occlusion after Interventional Surgery in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077116
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans of lower limbs

Interventions

Group of arteriosclerosis obliterans of lower limbs:This experiment is a real-world study and does not interfere with the medication treatment plan during the clinical diagnosis and treatment process

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age = 40 years old, = 85 years old, regardless of gender; (2) Patients who meet the diagnostic criteria for lower limb arteriosclerosis obliterans; (3) Patients with ankle brachial index>0.1 and no severe ulcers or gangrene in their limbs; (4) Rutherford staging: 2-5 levels; (5) Patients receiving interventional treatment; (6) Those who sign an informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Other diseases that affect walking distance, such as lower limb joint disease, spinal disease, neuropathy, etc; (2) Patients with liver and kidney dysfunction; (3) Diagnosed malignant tumors that pose a serious threat to survival, with an expected survival period of less than 1 year; (4) Pregnant and lactating women; (5) Participants in other clinical trials; (6) Researchers believe that other situations are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Vascular restenosis rate;

Secondary

MeasureTime frame
Postoperative patency rate;Intermittent limp distance;ankle brachial index;VAS;the MOS item short from health survey;End point event occurrence rate;The average blood flow velocity of the dorsalis pedis artery and the average blood flow velocity of the posterior tibial artery;adverse event;

Countries

China

Contacts

Public ContactLuxinwu

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

luxinwu@aliyun.com+86 136 5183 9016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026